Beta-3 Agonist and Anti-muscarinic Agent for Sjogren's Syndrome With Overactive Bladder
Conditions: Sjogren's Syndrome; Overactive Bladder Syndrome Interventions: Drug: mirabegron; Drug: oxybutynin, tolterodine, solifenacin Sponsor: China Medical University Hospital Not yet recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - June 1, 2021 Category: Research Source Type: clinical trials
Olfactory and Taste Disturbances in Sjogren's Syndrome
Condition: Sjogren's Syndrome Interventions: Other: Evaluation of olfactory function; Other: Evaluation of taste function; Other: Evaluation of (intra-nasal and oral) trigeminal functions Sponsor: Université de Reims Champagne-Ardenne Not yet recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - June 1, 2021 Category: Research Source Type: clinical trials
Beta-3 Agonist and Anti-muscarinic Agent for Sjogren's Syndrome With Overactive Bladder
Conditions: Sjogren's Syndrome; Overactive Bladder Syndrome Interventions: Drug: mirabegron; Drug: oxybutynin, tolterodine, solifenacin Sponsor: China Medical University Hospital Not yet recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - June 1, 2021 Category: Research Source Type: clinical trials
Olfactory and Taste Disturbances in Sjogren's Syndrome
Condition: Sjogren's Syndrome Interventions: Other: Evaluation of olfactory function; Other: Evaluation of taste function; Other: Evaluation of (intra-nasal and oral) trigeminal functions Sponsor: Université de Reims Champagne-Ardenne Not yet recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - June 1, 2021 Category: Research Source Type: clinical trials
Beta-3 Agonist and Anti-muscarinic Agent for Sjogren's Syndrome With Overactive Bladder
Conditions: Sjogren's Syndrome; Overactive Bladder Syndrome Interventions: Drug: mirabegron; Drug: oxybutynin, tolterodine, solifenacin Sponsor: China Medical University Hospital Not yet recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - June 1, 2021 Category: Research Source Type: clinical trials
Olfactory and Taste Disturbances in Sjogren's Syndrome
Condition: Sjogren's Syndrome Interventions: Other: Evaluation of olfactory function; Other: Evaluation of taste function; Other: Evaluation of (intra-nasal and oral) trigeminal functions Sponsor: Université de Reims Champagne-Ardenne Not yet recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - June 1, 2021 Category: Research Source Type: clinical trials
Beta-3 Agonist and Anti-muscarinic Agent for Sjogren's Syndrome With Overactive Bladder
Conditions: Sjogren's Syndrome; Overactive Bladder Syndrome Interventions: Drug: mirabegron; Drug: oxybutynin, tolterodine, solifenacin Sponsor: China Medical University Hospital Not yet recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - June 1, 2021 Category: Research Source Type: clinical trials
Olfactory and Taste Disturbances in Sjogren's Syndrome
Condition: Sjogren's Syndrome Interventions: Other: Evaluation of olfactory function; Other: Evaluation of taste function; Other: Evaluation of (intra-nasal and oral) trigeminal functions Sponsor: Université de Reims Champagne-Ardenne Not yet recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - June 1, 2021 Category: Research Source Type: clinical trials
Beta-3 Agonist and Anti-muscarinic Agent for Sjogren's Syndrome With Overactive Bladder
Conditions: Sjogren's Syndrome; Overactive Bladder Syndrome Interventions: Drug: mirabegron; Drug: oxybutynin, tolterodine, solifenacin Sponsor: China Medical University Hospital Not yet recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - June 1, 2021 Category: Research Source Type: clinical trials
Olfactory and Taste Disturbances in Sjogren's Syndrome
Condition: Sjogren's Syndrome Interventions: Other: Evaluation of olfactory function; Other: Evaluation of taste function; Other: Evaluation of (intra-nasal and oral) trigeminal functions Sponsor: Université de Reims Champagne-Ardenne Not yet recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - June 1, 2021 Category: Research Source Type: clinical trials
Beta-3 Agonist and Anti-muscarinic Agent for Sjogren's Syndrome With Overactive Bladder
Conditions: Sjogren's Syndrome; Overactive Bladder Syndrome Interventions: Drug: mirabegron; Drug: oxybutynin, tolterodine, solifenacin Sponsor: China Medical University Hospital Not yet recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - June 1, 2021 Category: Research Source Type: clinical trials
Olfactory and Taste Disturbances in Sjogren's Syndrome
Condition: Sjogren's Syndrome Interventions: Other: Evaluation of olfactory function; Other: Evaluation of taste function; Other: Evaluation of (intra-nasal and oral) trigeminal functions Sponsor: Université de Reims Champagne-Ardenne Not yet recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - June 1, 2021 Category: Research Source Type: clinical trials
